1-15 of 15
Jeremy Franklin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ruxolitinib Shows Efficacy in Patients with Newly-Diagnosed Polycythemia Vera: Futility Analysis of the Randomized Ruxo-BEAT Clinical Trial of the German Study Group for Myeloproliferative Neoplasms

Steffen Koschmieder, Susanne Isfort, Dominik Wolf, Univ. Prof. Dr., Florian H. Heidel, Philippe Schafhausen, Martin Griesshammer, MD, Denise Wolleschak, Uwe Platzbecker, Konstanze Döhner, Philipp J. Jost, MD, Stefani B. Parmentier, Nikolas von Bubnoff, Frank Stegelmann, MD, Angela Maurer, Jeremy Franklin, Martina Crysandt, MD, Deniz Gezer, Martin Hellmich, Tim H Brümmendorf, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2944.
https://doi.org/10.1182/blood-2019-123985
Published: 2019
Journal Articles

Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group

Clinical Trials & Observations
Dennis A. Eichenauer, Indra Thielen, Heinz Haverkamp, Jeremy Franklin, Karolin Behringer, Teresa Halbsguth, Beate Klimm, Volker Diehl, Stephanie Sasse, Achim Rothe, Michael Fuchs, Boris Böll, Bastian von Tresckow, Peter Borchmann, Andreas Engert
Journal: Blood
Blood (2014) 123 (11): 1658–1664.
https://doi.org/10.1182/blood-2013-07-512657
Published: 2014
Includes: Supplemental data
Journal Articles

Systematic Review and Individual Patient Data Meta-Analysis Of Treatment-Related Risk Of Secondary Malignant Neoplasms After Hodgkin Lymphoma

Jeremy Franklin, PhD, Dennis A. Eichenauer, MD, Ingrid Becker, MSc, Andreas Engert, MD
Journal: Blood
Blood (2013) 122 (21): 1753.
https://doi.org/10.1182/blood.V122.21.1753.1753
Published: 2013
Journal Articles

Hodgkin Lymphoma in Adolescents Treated with Adult Protocols: An Analysis From the German Hodgkin Study Group (GHSG).

Dennis A. Eichenauer, Henning Bredenfeld, Jeremy Franklin, Heinz Haverkamp, Horst Mueller, Hans T. Eich, Rolf-Peter Mueller, Michael Fuchs, Peter Borchmann, Volker Diehl, Andreas Engert
Journal: Blood
Blood (2009) 114 (22): 719.
https://doi.org/10.1182/blood.V114.22.719.719
Published: 2009
Journal Articles

Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma

Clinical Trials & Observations
Carsten Kobe, Markus Dietlein, Jeremy Franklin, Jana Markova, Andreas Lohri, Holger Amthauer, Susanne Klutmann, Wolfram H. Knapp, Josee M. Zijlstra, Andreas Bockisch, Matthias Weckesser, Reinhard Lorenz, Mathias Schreckenberger, Roland Bares, Hans T. Eich, Rolf-Peter Mueller, Michael Fuchs, Peter Borchmann, Harald Schicha, Volker Diehl, Andreas Engert
Journal: Blood
Blood (2008) 112 (10): 3989–3994.
https://doi.org/10.1182/blood-2008-06-155820
Published: 2008
Journal Articles

Differences in Survival Rates for Patients with Hodgkin Lymphoma, Who Were Treated Inside vs. Outside Therapy Optimisation Protocols in Germany.

Corinne Brillant, Claudia Terschueren, Sylke Gierer, Jeremy Franklin, Stephanie Heidelbach, Ursula Paulus, Volker Diehl, Wolfgang Hoffmann
Journal: Blood
Blood (2007) 110 (11): 2321.
https://doi.org/10.1182/blood.V110.11.2321.2321
Published: 2007
Journal Articles

Long-Term Follow-Up of BEACOPP escalated Chemotherapy in Patients with Advanced-Stage Hodgkin Lymphoma on Behalf of the German Hodgkin Study Group.

Engert Andreas, Jeremy Franklin, Volker Diehl
Journal: Blood
Blood (2007) 110 (11): 211.
https://doi.org/10.1182/blood.V110.11.211.211
Published: 2007
Journal Articles

HD12 Randomised Trial Comparing 8 Dose-Escalated Cycles of BEACOPP with 4 Escalated and 4 Baseline Cycles in Patients with Advanced Stage Hodgkin Lymphoma (HL): An Analysis of the German Hodgkin Lymphoma Study Group (GHSG), University of Cologne, D-50924 Cologne, Germany.

Andreas Engert, Jeremy Franklin, Rolf-Peter Mueller, Hans-Theodor Eich, Axel Gossmann, Hans Konrad Mueller-Hermelink, Thomas Cerny, Jana Markova, Anthony D. Ho, Lothar Kanz, Richard Greil, Wolfgang Hiddemann, Beate Pfistner, Volker Diehl
Journal: Blood
Blood (2006) 108 (11): 99.
https://doi.org/10.1182/blood.V108.11.99.99
Published: 2006
Journal Articles

Identification of Prognostic Factors in Early Unfavorable Stage Hodgkin’s Lymphoma (HL): An Individual Patient Data Meta-Analysis.

Julia Bohlius, Heinz Haverkamp, Volker Diehl, Houchingue Eghbali, Christopher Ferme, Jeremy Franklin, Beate Pfistner, Petra Schiller, John Raemaekers, Andreas Engert, Michel Henry-Amar
Journal: Blood
Blood (2006) 108 (11): 2473.
https://doi.org/10.1182/blood.V108.11.2473.2473
Published: 2006
Journal Articles

Identification of Prognostic Factors in Patients with Early Stage Unfavorable Hodgkin’s Lymphoma: An Individual Patient Data Meta-Analysis.

Julia Bohlius, MD, MScPH, Heinz Haverkamp, MSc, Volker Diehl, MD, Houchingue Eghbali, MD, Jeremy Franklin, MSc, Beate Pfistner, MSc, John Raemaekers, MD, PhD, Andreas Engert, MD, Michel Henry-Amar, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 5577.
https://doi.org/10.1182/blood.V106.11.5577.5577
Published: 2005
Journal Articles

Outcome of Patients Progressing or Relapsing after Primary Treatment with Two Cycles of Chemotherapy and Radiotherapy for Early Stage (Favorable) Hodgkin’s Disease.

Andreas Josting, MD, Jeremy Franklin, PhD, Michal Sieniawski, MD, Beate Pfistner, PhD, Thomas Schober, Hildtrud Nisters-Backes, Andreas Engert, MD, Volker Diehl, MD
Journal: Blood
Blood (2005) 106 (11): 818.
https://doi.org/10.1182/blood.V106.11.818.818
Published: 2005
Journal Articles

Mortality during Treatment of Patients with Advanced Hodgkin’s Lymphoma Undergoing Dose Escalated BEACOPP Chemotherapy: An Analysis of the German Hodgkin Study Group (GHSG).

Michael Fuchs, Jeremy Franklin, Beate Klimm, Andreas Josting, Beate Pfistner, Andreas Engert, Volker Diehl
Journal: Blood
Blood (2005) 106 (11): 2668.
https://doi.org/10.1182/blood.V106.11.2668.2668
Published: 2005
Journal Articles

Nodular sclerosing Hodgkin disease: new grading predicts prognosis in intermediate and advanced stages

Clinical Trials & Observations
Sabine von Wasielewski, Jeremy Franklin, Robert Fischer, Klaus Hübner, Martin L. Hansmann, Volker Diehl, Axel Georgii, Reinhard von Wasielewski
Journal: Blood
Blood (2003) 101 (10): 4063–4069.
https://doi.org/10.1182/blood-2002-05-1548
Published: 2003
Journal Articles

European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes

Clinical Trials & Observations
Ioannis Anagnostopoulos, Martin-Leo Hansmann, Kaarle Franssila, Martin Harris, Nancy L. Harris, Elaine S. Jaffe, J. Han, J. M. van Krieken, Sibrand Poppema, Teresa Marafioti, Jeremy Franklin, Michael Sextro, Volker Diehl, Harald Stein
Journal: Blood
Blood (2000) 96 (5): 1889–1899.
https://doi.org/10.1182/blood.V96.5.1889
Published: 2000
Journal Articles

Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group

Clinical Trials & Observations
Andreas Josting, Ulrich Rueffer, Jeremy Franklin, Markus Sieber, Volker Diehl, Andreas Engert
Journal: Blood
Blood (2000) 96 (4): 1280–1286.
https://doi.org/10.1182/blood.V96.4.1280
Published: 2000